Biocartis Group NV
Develops an automated PCR platform for fast molecular diagnostics in oncology & infectious diseases.
BCART | BR
Overview
Corporate Details
- ISIN(s):
- BE0974281132 (+1 more)
- LEI:
- 549300J4HOJL5KG8HY54
- Country:
- Belgium
- Address:
- GENERAAL DE WITTELAAN 11 BOÎTE B, 2800 MECHELEN
- Website:
- https://www.biocartis.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Biocartis Group NV is an innovative molecular diagnostics company committed to revolutionizing molecular testing. The company develops and commercializes its unique, proprietary Idylla™ platform, a fully automated, real-time PCR-based system designed to provide fast, easy, and actionable molecular diagnostic results. Biocartis' mission is to enable personalized medicine and improve patient outcomes by making molecular testing accessible to any lab, regardless of size or expertise. The company's primary focus is on providing tests for oncology and infectious diseases.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Biocartis Group NV and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-25 00:00 |
Post-Annual General Meeting Information
Biocartis Group - AGM 2025 - Written Questions and Responses (NL) - Final (25 A…
|
Dutch | 278.1 KB | |
| 2025-08-25 00:00 |
Post-Annual General Meeting Information
Biocartis Group - AGM 2025 - Minutes (ENG) (25 August 2025).pdf
|
English | 226.4 KB | |
| 2025-08-25 00:00 |
Post-Annual General Meeting Information
Biocartis Group - AGM 2025 - Minutes (NL) (25 August 2025).pdf
|
Dutch | 345.3 KB | |
| 2025-07-25 00:00 |
Audit Report / Information
Auditor Report - Consolidated Financial Statements FY 2023.pdf
|
English | 253.5 KB | |
| 2025-07-25 00:00 |
Annual Report
Annual report 2023.pdf
|
English | 1.2 MB | |
| 2025-07-25 00:00 |
Legal Proceedings Report
Board report (7-228).pdf
|
English | 253.0 KB | |
| 2025-07-25 00:00 |
Audit Report / Information
Auditor Report - Statutory Financial Statements FY 2023.pdf
|
English | 254.0 KB | |
| 2025-07-25 00:00 |
Management Discussion and Analysis
Verslag Raad van bestuur (7-228).pdf
|
Dutch | 258.5 KB | |
| 2025-07-25 00:00 |
Annual / Quarterly Financial Statement
Statutaire jaarrekening FY 2023 - Statutory annual accounts FY 2023.pdf
|
Dutch | 108.9 KB | |
| 2025-07-25 00:00 |
Pre-Annual General Meeting Information
Deelnemingsformulier - Attendance form.pdf
|
Dutch | 120.1 KB | |
| 2025-07-25 00:00 |
Proxy Solicitation & Information Statement
Volmacht - Proxy.pdf
|
Dutch | 270.8 KB | |
| 2025-07-25 00:00 |
Proxy Solicitation & Information Statement
Formulier voor stemming per brief - Vote by mail form.pdf
|
Dutch | 267.9 KB | |
| 2025-07-25 00:00 |
Audit Report / Information
Commissarisverslag - Geconsolideerde Jaarrekening FY 2023.pdf
|
Dutch | 276.0 KB | |
| 2025-07-25 00:00 |
Annual / Quarterly Financial Statement
Statutair jaarverslag 2023 - Statutory annual report 2023.pdf
|
Dutch | 582.2 KB | |
| 2025-07-25 00:00 |
Audit Report / Information
Commissarisverslag - Statutaire Jaarrekening FY 2023.pdf
|
Dutch | 260.9 KB |
Automate Your Workflow. Get a real-time feed of all Biocartis Group NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Biocartis Group NV via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-04-29 | Devogelaere Benoit | Executive member | Buy | 15,000 | N/A |
| 2021-04-28 | Marcofin BV | Executive member | Buy | 30,000 | N/A |
| 2021-04-27 | Herman Verrelst | Board | Buy | 60,000 | N/A |
| 2020-11-13 | Devogelaere Benoit | Executive member | Buy | 50,000 | N/A |
| 2020-05-06 | Herman Verrelst | Board | Buy | 50,000 | 249,625.00 EUR |
| 2020-05-06 | Herman Verrelst | Board | Buy | 300,000 | N/A |
| 2020-05-04 | Herman Verrelst | Board | Buy | 46,803 | 231,656.00 EUR |
| 2020-05-04 | Herman Verrelst | Board | Buy | 3,197 | 15,315.00 EUR |
| 2019-12-18 | Devogelaere Benoit | Executive member | Buy | 50,000 | N/A |
| 2019-12-16 | Welten Ewoud | Executive member | Buy | 10,000 | N/A |
